Atovaquone and Proguanil Hydrochloride
NDC 0378-4162, atovaquone and proguanil hydrochloride, tablet, film coated, from Mylan Pharmaceuticals Inc..
- Product NDC
- 0378-4162
- Status
- Listed
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202362
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0378-4162 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATOVAQUONE250 mg/1
- PROGUANIL HYDROCHLORIDE100 mg/1
Pharmacologic classes
Antimalarial [EPC]; Antimalarial [EPC]; Antiprotozoal [EPC]; Dihydrofolate Reductase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0378-4162-01 | 00378416201 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-4162-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/57d74d71-8cf8-4b10-9420-22954fae623cNADAC price for package 00378416201
GET /v1/drugs/nadac/00378416201
Use it
Look up 0378-4162 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0378-4162 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0378-4162. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.